[Mazur-A-capsules in the treatment of peptic ulcer. Preliminary report].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002266:Carboxymethylcellulose Sodium / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008277:Magnesium Oxide / Q000627:therapeutic use*; D008297:Male; D008747:Methylcellulose / Q000031:analogs & derivatives*; D008875:Middle Aged; D010208:Papaverine / Q000627:therapeutic use*; D010437:Peptic Ulcer / Q000188:drug therapy*; D010634:Phenobarbital / Q000627:therapeutic use*
D004338:Drug Combinations; D008277:Magnesium Oxide; D008747:Methylcellulose; D010208:Papaverine; D002266:Carboxymethylcellulose Sodium; D010634:Phenobarbital
Mazur-A-Kapseln in der Therapie des Ulcus pepticum. Vorläufige Mitteilung.